TUESDAY EARNINGS DIGEST: 18 reporters, all pre-market. Scorecard: 0 beats, 0 misses, 18 in-line. Heavy Financials tilt ($SCHW, $IBKR, $CB, $COF, $MRSH, $MSCI, $KEY, $SYF). Widest consensus spread was

$SCHW posted EPS of $1.43, dead-on with consensus. No beat on a day where fintech sentiment needed a win. Revenue details still parsing, but the in-line print won't shake the macro caution hanging over the broker space. $GM delivered EPS of $3.70 vs $2.64 consensus. That's a massive beat on paper, but shares barely twitched. The whisper number was sky-high, and guidance is the real battleground — investors want to know if peak auto profits are already here. $DHR reported EPS of $2.06 vs $1.94 consensus, in-line. The life sciences giant is a bellwether for biotech spending, but a "meet" isn't enough to reverse the sector's recent cold streak. All eyes on the call for capex commentary. $COF came in at $4.42 vs $4.57 consensus, in-line. Credit quality metrics are the real story here — charge-off rates and reserve builds will dictate whether this "in-line" print is actually a warning shot for consumer health. $HAL printed $0.55 vs $0.50 consensus, in-line. North American activity is th

$SCHW posted EPS of $1.43, dead-on with consensus. No beat on a day where fintech sentiment needed a win. Revenue details still parsing, but the in-line print won't shake the macro caution hanging over the broker space.